{
    "nctId": "NCT05725265",
    "briefTitle": "LLLT for BCRL: a Randomized, Placebo-controlled Study",
    "officialTitle": "Large-area Low-level Laser Therapy for Breast Cancer-related Lymphedema: a Randomized, Placebo-controlled Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "Circumference discrepancy of bilateral upper arm",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female subjects, 20 years age or older, suffered from unilateral breast cancer with ipsilateral lumpectomy or mastectomy and lymph node dissection (sentinel biopsy or axillary dissection)\n* Stage I or II unilateral secondary upper extremity lymphedema(as defined by the International Society of Lymphology)\n* Girth\u2265 2 cm circumferential difference compared with the uninvolved upper extremity at any 4 cm segment\n* Able to commit to a long-term follow-up schedule\n\nExclusion Criteria:\n\n* Metastatic cancer(stage IV)\n* Pregnancy\n* Presence of other extremity lymphedema (primary or secondary)\n* History of deep vein thrombosis\n* Pacemaker\n* Artificial joints, implant or tattoo(area\u22654 cm2) at the involved upper extremity\n* Previous treatment with low-level laser therapy (within 3 months)\n* Body mass index (BMI) \\> 35 (morbid obesity)\n* High bleeding tendency(hemophilia)\n* Receiving long-term steroid treatment (oral or systemic)",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}